EXAMINE THIS REPORT ON TRASTUZUMAB BRAND NAME

Gastric cancer, metastatic: Procedure of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma (in combination with cisplatin and possibly capecitabine or 5-fluorouracil) in sufferers who may have not been given prior therapy for metastatic illness.Info from a small section II examine help using trastuzumab in combinati